Have you ever thought about working for a large global corporation who care about their culture, developing their staff and having a positive impact on the world? Or do you know anyone who has?
In April 2019, Arrival Education and GSK are launching a brand new 7-month part-time programme to help members of the Arrival Network, and their family and friends, get ready for graduate and industrial placement applications opening this Autumn. Even if this opportunity isn’t for you please forward to anyone relevant.
Who can apply?
- You have recently graduated from university, or are due to graduate this summer;
- You are due to graduate in 2020;
- You are looking for an industrial placement in business or pharma, starting in Summer / Autumn 2020
- You are interested in a career in finance
- You have completed, or are studying towards a degree in Finance, Economics, Maths, Physics, Business, Engineering or another science
Coaching & application support
Work with a senior leader and someone who is either on, or has recently completed the grad scheme.
Success skill seminars
3 seminars to help you develop the skills and behaviours GSK look for in successful applicants.
Opportunity to find out about a career at GSK, including their commitment to socially and ethnically diverse talent.
Opportunity to present your programme experiences and insights to GSK executives and receive completion certificate.
How do you apply?
Complete the form by midnight on Thursday 14th March. It takes just a few minutes! Remember to share with your networks too!
We have been working with GSK for 5 years on various coaching programmes and recruitment support, with one of our Arrival Network graduates to join later this year on their grad scheme. We firmly believe that GSK has a real commitment to helping talented individuals within the Arrival Network achieve their goals!
GSK is a diverse firm of roughly 100,000 employees, with a female CEO and opportunities for their staff to work across the globe and a very strong coaching culture. They are the third largest pharmaceutical company in the UK and are continuing to grow and innovate.